Illustration: Gabriella Turrisi/Axios
Soccer star David Beckham is teaming with genomics company Prenetics (Nasdaq: PRE), taking a 4% stake in its new supplements brand IM8, CEO Danny Yeung tells Axios.
Why it matters: Sales of supplements aimed at enhancing healthy aging are expected to pass $1 billion in 2026, up from nearly $840 million in 2023, per Nutrition Business Journal.
